Nomad Foods
NOMD
11.00
+0.03
+0.27%
Nomad Foods
US · NOMD
#2991 by market cap
Listed 2016
11.00
+0.03
+0.27%
Live - 5344 symbols - heartbeat 254s ago
· 2026-10-08 07:34
Pre-market
11.19
+1.73%
After-hours
11.00
0.00%
- Market cap
- 1.54B
- P/E (TTM)i
- 11.29
- P/Bi
- 0.55
- EPSi
- 1.02
- Div yieldi
- 6.04%
- 52W posi
- 56%
Reader sentiment
Are you bullish or bearish on NOMD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.22, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.17% YoY
Margins
- Gross margin
- 27.14%
- Operating margin
- 13.32%
- Net margin
- 4.51%
Key ratios & quality
- Enterprise valuei
- 3.44B
- Altman Z-Scorei
- 1.22
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.17B | 2.32B | 2.52B | 2.61B | 2.94B | 3.04B | 3.10B | 3.03B |
| Gross profit | 653.50M | 697.90M | 762.50M | 744.30M | 815.30M | 858.70M | 917.80M | 823.00M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 300.80M | 338.00M | 379.80M | 388.00M | 424.10M | 412.90M | 456.50M | 403.80M |
| Pretax profit | 227.10M | 210.30M | 295.50M | 236.70M | 321.00M | 253.60M | 277.90M | 145.30M |
| Tax | 56.60M | 56.70M | 70.40M | 55.70M | 71.20M | 60.90M | 50.80M | 8.60M |
| Net profit | 170.50M | 153.60M | 225.10M | 181.00M | 249.80M | 192.70M | 227.10M | 136.70M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.97 | 0.78 | 1.14 | 1.02 | 1.43 | 1.13 | 1.40 | 0.91 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 760.10M | 746.90M | 752.40M | 773.10M | 715.20M | 723.70M |
| Gross profit | 211.60M | 206.30M | 207.40M | 197.70M | 183.60M | 209.20M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 90.90M | 102.40M | 110.50M | 100.00M | 66.60M | 101.60M |
| Pretax profit | 39.70M | 70.60M | 70.40M | -35.40M | 35.30M | 60.10M |
| Tax | 7.00M | 13.50M | 12.80M | -24.70M | 6.40M | 11.60M |
| Net profit | 32.70M | 57.10M | 57.60M | -10.70M | 28.90M | 48.50M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.21 | 0.37 | 0.39 | -0.07 | 0.20 | 0.35 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 936.80M | 1.42B | 968.40M | 929.10M | 1.12B | 1.17B | 1.23B | 1.15B |
| Cash & ST investments | 327.50M | 851.00M | 418.10M | 254.00M | 369.40M | 412.70M | 403.00M | 324.00M |
| Inventory | 342.50M | 323.20M | 344.30M | 410.60M | 457.10M | 446.40M | 441.50M | 440.60M |
| Total assets | 5.34B | 5.90B | 5.58B | 6.17B | 6.33B | 6.42B | 6.43B | 6.34B |
| Total current liabilities | 840.00M | 823.10M | 917.10M | 966.20M | 940.80M | 1.03B | 1.12B | 1.07B |
| Short-term debt | 21.40M | 29.00M | 33.20M | 29.10M | 25.50M | 34.60M | 26.00M | 32.60M |
| Long-term debt | 1.74B | 1.76B | 1.68B | 2.14B | 2.10B | 2.06B | 2.08B | 2.20B |
| Total liabilities | 3,281,700,000.00 | 3,347,800,000.00 | 3,454,500,000.00 | 3,871,800,000.00 | 3,719,900,000.00 | 3,824,800,000.00 | 3,769,100,000.00 | 3,838,200,000.00 |
| Total equity | 2.06B | 2.56B | 2.13B | 2.30B | 2.61B | 2.59B | 2.66B | 2.50B |
| Retained earnings | -167.90M | -11.80M | 191.60M | 387.40M | 886.60M | 1.06B | 1.20B | 1.26B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.22B | 1.19B | 1.14B | 1.15B | 1.15B | 1.19B |
| Cash & ST investments | 329.80M | 266.60M | 193.60M | 324.00M | 282.50M | 273.40M |
| Inventory | 462.50M | 461.10M | 485.30M | 440.60M | 443.20M | 470.80M |
| Total assets | 6.40B | 6.38B | 6.31B | 6.34B | 6.34B | 6.38B |
| Total current liabilities | 1.15B | 1.16B | 1.12B | 1.07B | 1.08B | 1.08B |
| Short-term debt | 27.50M | 29.90M | 28.50M | 32.60M | 35.20M | 33.70M |
| Long-term debt | 2.12B | 2.07B | 2.08B | 2.20B | 2.27B | 2.28B |
| Total liabilities | 3,786,400,000.00 | 3,812,400,000.00 | 3,758,800,000.00 | 3,838,200,000.00 | 3,840,900,000.00 | 3,861,300,000.00 |
| Total equity | 2.61B | 2.56B | 2.55B | 2.50B | 2.50B | 2.52B |
| Retained earnings | 1.21B | 1.24B | 1.28B | 1.26B | 1.27B | 1.29B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 321.30M | 315.40M | 457.00M | 306.30M | 303.80M | 430.80M | 435.40M | 330.70M |
| Depreciation & amortization | 46.30M | 68.30M | 67.60M | 71.60M | 88.60M | 95.00M | 96.90M | 109.40M |
| Free cash flow | 279.70M | 268.10M | 398.30M | 227.10M | 224.70M | 348.40M | 355.10M | 252.20M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | -89.20M | -91.30M |
| Stock buybacks / issuance | 100.00K | 354.10M | -627.20M | -100.20M | -29.70M | -178.00M | -124.50M | -202.50M |
| Ending cash balance | 327.60M | 824.80M | 382.50M | 254.20M | 366.80M | 399.70M | 403.30M | 324.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 50.60M | 69.60M | 54.00M | 156.50M | 38.30M | 81.40M |
| Depreciation & amortization | 24.00M | 26.30M | 29.60M | 29.50M | 24.30M | 25.90M |
| Free cash flow | 31.90M | 51.20M | 31.50M | 137.60M | 17.30M | 65.00M |
| Dividends paid | -25.30M | -23.10M | -21.30M | -21.60M | -20.60M | -20.30M |
| Stock buybacks / issuance | -48.90M | -58.20M | -51.00M | -44.40M | -23.90M | -200.00K |
| Ending cash balance | 329.80M | 266.60M | 193.60M | 324.80M | 282.50M | 273.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.75 | 6.67 | 9.62 | 8.18 | 10.19 | 7.41 | 8.64 | 5.30 |
| ROA %i | 3.44 | 2.74 | 3.92 | 3.08 | 4.00 | 3.02 | 3.54 | 2.14 |
| ROIC %i | 6.31 | 5.15 | 6.61 | 5.41 | 6.74 | 6.07 | 6.79 | 4.95 |
| 5-year avg ROE %i | -- | -- | 6.85 | 8.10 | 8.68 | 8.41 | 8.81 | 7.94 |
| EBIT margin %i | 13.64 | 12.61 | 14.40 | 11.44 | 13.73 | 12.66 | 13.17 | 8.55 |
| FCF / sales %i | 12.87 | 11.53 | 15.83 | 8.71 | 7.64 | 11.44 | 11.46 | 8.32 |
| Current ratioi | 1.12 | 1.73 | 1.06 | 0.96 | 1.19 | 1.13 | 1.10 | 1.07 |
| Quick ratioi | 0.60 | 1.29 | 0.66 | 0.51 | 0.68 | 0.70 | 0.69 | 0.66 |
| Debt / assetsi | 33.03 | 31.78 | 31.71 | 36.10 | 34.27 | 33.48 | 33.85 | 36.17 |
| LT debt / equityi | 84.61 | 72.23 | 81.67 | 95.62 | 82.20 | 81.55 | 80.80 | 90.46 |
| Interest coveragei | 4.28 | 3.54 | 5.43 | 4.85 | 4.89 | 2.92 | 3.13 | 2.27 |
| Revenue CAGR (3Y) %i | -- | 6.43 | 8.74 | 6.26 | 8.14 | 6.56 | 5.95 | 1.04 |
| Net income CAGR (3Y) %i | -- | 61.74 | 18.16 | 1.87 | 17.50 | -5.06 | 7.86 | -18.21 |
| FCF CAGR (3Y) %i | -- | 3.80 | 38.11 | -6.71 | -5.72 | -4.36 | 16.07 | 3.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.61 | 8.09 | 7.60 | 5.30 | 5.20 | 4.89 |
| ROA %i | 3.50 | 3.31 | 3.11 | 2.14 | 2.09 | 1.95 |
| ROIC %i | 6.85 | 6.67 | 6.20 | 4.95 | 4.65 | 4.81 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.19 | 12.48 | 11.76 | 8.55 | 8.31 | 8.26 |
| FCF / sales %i | 9.97 | 11.95 | 10.37 | 8.32 | 7.95 | 8.48 |
| Current ratioi | 1.06 | 1.02 | 1.02 | 1.07 | 1.06 | 1.10 |
| Quick ratioi | 0.66 | 0.62 | 0.58 | 0.66 | 0.65 | 0.66 |
| Debt / assetsi | 33.61 | 32.97 | 33.36 | 36.17 | 36.30 | 36.25 |
| LT debt / equityi | 81.24 | 80.84 | 81.33 | 90.46 | 90.71 | 90.50 |
| Interest coveragei | 3.12 | 3.08 | 3.07 | 2.27 | 2.31 | 2.14 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- United Kingdom is the largest reported line at 27.35% of revenue, across 10 reported segments.
- No single line clears half of revenue; Rest of Europe is next at 12.99%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Region
United Kingdom27.35%
Rest of Europe12.99%
Italy12.88%
Germany12.38%
Other9.24%
France7.07%
Croatia4.80%
Sweden4.70%
Serbia4.36%
Austria4.23%
Quote time 2026-10-08 07:34:37 · For reference only, not investment advice and not tailored to your situation.